XML 145 R80.htm IDEA: XBRL DOCUMENT v3.24.0.1
Share-based compensation and stockholders' equity - Stock-based Compensation Expense (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]      
Total share-based compensation expense $ 23.1 $ 45.1 $ 42.4
Cost of product sales | Commercial Product sales      
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]      
Total share-based compensation expense 0.1 0.8 1.0
Cost of product sales | MCM Product sales      
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]      
Total share-based compensation expense 3.8 6.5 5.4
Cost of product sales | Bioservices      
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]      
Total share-based compensation expense 1.0 1.8 1.1
R&D      
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]      
Total share-based compensation expense 2.0 5.4 5.0
Selling, general and administrative      
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]      
Total share-based compensation expense $ 16.2 $ 30.6 $ 29.9